1Johnson ML, Rajamannan N. Diseases of Wnt signaling[J]. Rev Endocr Metab Disord, 2006,7(1 2):41-49.
2Brade T, Manner J, Kuhl M. The role of Wnt signalling in cardiac development and tissue remodelling in the mature heart[J]. Cardiovas Res, 2006,72(2) : 198-209.
3Yang DH, Yoon JY, Lee SH, et al. Wntra is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/betacatenin and protein kinase Calpha[J]. Circ Res, 2009,104(3):372-379.
4Wang H, Charles PC, Wu Y, et al. Gene expression profile signatures indicate a role for Wnt signaling in endothelial commitment from embryonic stem cells[J]. Circ Res, 2006, 98(10) : 1331-1339.
5Franco CA, Liebner S, Gerhardt H. Vascular morphogenesis: a Wnt for every vessel? [J]. Curr Opin Genet Dev, 2009,19(5) :476-483.
6Gelfand BD, Meller J, Pryor AW, et al. Hemodynamic activation of beta-catenin and T-cell specific transcription factor signaling in vascular endothelium regulates fibronectin expression[J]. Arterioscler Thromb Vasc Biol, 2()11,31 (7): 1625- 1633.
7Kim J, Kim J, Kim DW, et al. Wntsa induces endothelial inflammation via beta-catenin-independent signaling [J]. J Immunol, 2010,185(2) : 1274- 1282.
8Tsaousi A, Williams H, Lyon CA, et al. Wnt4/beta eatenin signaling induces VSMC proliferation and is associated with intimal thickening[J]. Circ Res, 2011,108(4) :427-436.
9Cipolletta E, Monaco S, Maione AS, et al. Calmodulin dependent kinase Ⅱ mediates vascular smooth muscle cell proliferation and is potentiated by extraeellular signal regulated kinase[J]. Endocrinology, 2010,151 (6) :2747-2759.
10Wu X, Wang J, Jiang H, et al. Wnt3a activates betal- integrin and regulates migration and adhesion of vascular smooth muscle cells [J]. Mol Med Rep, 2014, 9 (4): 1159-1164.
二级参考文献20
1Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/ HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines [J].Circulation, 2011, 123 ( 10 ) : e269-e367.
2Mahida S, Lubitz SA, Rienstra M, et al. Monogenic atrial fibrillation as pathophysiological paradigms[J]. Cardiovasc Res, 2011, 89(4): 692- 700.
3Chaldoupi SM, Loh P, Hauer RN, et al. The Role of connexin40 in atrial fibrillation [J]. Cardiovasc Res, 2009, 84 ( 1 ) : 15-23.
4Groenewegen WA, Firouzi M, Bezzina CR. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill [J]. Circ Res, 2003, 92(1): 14-22.
5Hauer RN, Groenewegen WA, Firouzi M, et al. Cx40 polymorphism in human atrial fibrillation [J]. Adv Cardiol, 2006, 42:284-291.
6Juang JM, Chern YR, Tsai CT, et al. The association of human connexln 40 genetic polymorphisms with atrial fibrillation[J]. Int J Cardio, 2007, 116(1): 107-112.
7Gollob MH, Jones DL, Krahn AD, et al. Somatic mutations in the connexin 40 gene(GJAS) in atrial fibrillation[J]. N Engl J Med, 2006, 354(25) : 2677-2688.
8Yang YQ, Liu X, Zhang XL, et al. Novel connexin40 rnissense mutations in patients with familial atrial fibrillation [J]. Europaee, 2010, 12(10) : 1421-1427.
9Yang YQ, Zhang XL, Wang XH, et al. Connexin40 nonsense mutation in familial atrial fibrillation[J]. Int J Mol Med, 2010, 26(4) : 605-610.
10Wirka RC, Gore S, Van Wagoner DR, et al. A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2011, 4 ( 1 ) : 87-93.
